1. Clinical Overview
Naphazoline is a direct-acting sympathomimetic amine (alpha-adrenergic agonist) used primarily as a topical decongestant for ocular and nasal hyperemia. In the 0.1% w/v concentration, it is indicated for ophthalmic use to provide rapid relief from redness and minor irritation by constricting the conjunctival blood vessels. It is an over-the-counter medication widely used in India for symptomatic relief.
| Onset | Duration | Bioavailability |
|---|---|---|
| Within 10 minutes of topical ocular administration. | 2 to 6 hours. | Negligible systemic absorption following proper topical ophthalmic use. Primarily local action. |
2. Mechanism of Action
Naphazoline acts as a potent vasoconstrictor by stimulating alpha-1 adrenergic receptors on the smooth muscle of the conjunctival and nasal blood vessels. This stimulation leads to smooth muscle contraction, resulting in vasoconstriction, reduced blood flow, decreased vascular permeability, and reduced tissue edema. This mechanism rapidly relieves redness and congestion.
3. Indications & Uses
- Symptomatic relief of ocular redness (conjunctival hyperemia) due to minor irritants (smoke, dust, swimming, fatigue).
- As a nasal decongestant for temporary relief of nasal congestion due to common cold, sinusitis, or allergic rhinitis (in specific nasal formulations).
4. Dosage & Administration
Adult Dosage: Ophthalmic: Instill 1 or 2 drops into the affected eye(s) every 3 to 4 hours as needed. Do not exceed 4 doses in 24 hours. Nasal: 1-2 sprays or drops per nostril every 4-6 hours as needed.
Administration: For eyes: Wash hands. Tilt head back, pull lower eyelid down to form a pouch. Instill drops without touching the dropper tip to eye or any surface. Close eyes gently for 1-2 minutes. Apply gentle pressure to the inner corner of the eye (nasolacrimal duct) for 1 minute to minimize systemic absorption. Wait at least 5 minutes before instilling any other eye drops.
5. Side Effects
Common side effects may include:
- Transient stinging or burning upon instillation
- Blurred vision temporarily
- Mydriasis (dilated pupil)
- Rebound hyperemia/redness with prolonged use
- Headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) - Tranylcypromine, Phenelzine | Risk of severe hypertensive crisis due to potentiation of pressor effects. | High |
| Tricyclic Antidepressants (TCAs) - Amitriptyline, Imipramine | May potentiate pressor effects of naphazoline. | Moderate |
| Beta-blockers (Ophthalmic) - Timolol, Betaxolol | Potential additive effect on intraocular pressure; may also increase risk of systemic hypertension/bradycardia. | Moderate |
| Other Sympathomimetics (Pseudoephedrine, Phenylephrine) | Additive systemic effects leading to hypertension, tachycardia, and arrhythmias. | Moderate |
| Antihypertensives | Naphazoline may counteract the blood pressure-lowering effect. | Moderate |
7. Patient Counselling
- DO wash hands before use.
- DO apply pressure to the inner corner of the eye for 1 minute after instillation.
- DO not use for more than 3 to 4 days in a row.
- DO not share the bottle with others.
- DO not use if the solution is discolored or contains particles.
- DO wait at least 5 minutes before using other eye drops.
- DO NOT touch the dropper tip to your eye, fingers, or any surface.
- DO NOT use while wearing contact lenses. Remove lenses before use and wait at least 15 minutes before reinserting.
8. Toxicology & Storage
Overdose: Ophthalmic Overuse: Severe rebound conjunctival hyperemia, chemosis, corneal damage. Systemic Overdose (esp. in children): Profound CNS depression (drowsiness, hypothermia, sweating, coma), bradycardia, hypotension (may be preceded by hypertension), respiratory depression, apnea, cardiovascular collapse.
Storage: Store at room temperature (15-25°C), protected from light. Do not freeze. Keep the bottle tightly closed when not in use. Keep out of reach and sight of children. Discard the bottle 28 days after first opening to prevent contamination.